Connect Biopharma shares are trading higher after Oppenheimer initiated its coverage on the stock with a Outperform rating and announced a price target of $8.
Connect Biopharma shares are trading higher after Oppenheimer initiated its coverage on the stock with a Outperform rating and announced a price target of $8.
benzinga_article
Connect Biopharma shares are trading higher after Oppenheimer initiated its coverage on the stock with a Outperform rating and announced a price target of $8.
